Attenuation of early and late phase allergen-induced bronchoconstriction in asthmatic subjects by a 5-lipoxygenase activating protein antagonist, BAYx 1005.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples